CyberKnife Radiosurgery – Value as an Adjunct to Surgical Treatment of HCC?
admin2023-01-12T16:31:01+01:00Hepatocellular carcinoma: The study evaluated the long-lasting anti-tumor effects of … ›
Hepatocellular carcinoma: The study evaluated the long-lasting anti-tumor effects of … ›
The “InCise™ multileaf-collimator (MLC)” is the first commercial MLC to be mounted on a robotic SRS/SBRT platform (CyberKnife)
Consensus statement from the International Radiosurgery Oncology Consortium for Kidney for primary renal cell carcinoma
Response assessment after stereotactic body radiotherapy for spinal metastasis: report … ›
Quality of life in the follow-up of uveal melanoma patients … ›
Robotic radiosurgery for the treatment of medium and large uveal … ›
CyberKnife radiosurgery leading to long-lasting complete remission in locally relapsed … ›
Progression-free Survival Following Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer … ›
Stereotactic body radiotherapy for centrally located early-stage non-small cell lung … ›
Unsere radiochirurgischen Behandlungsmethoden werden gegen Tumore im ganzen Körper eingesetzt.
Erhalten Sie hier detaillierte Informationen zu unserer Cyberknife-Behandlung.
Unser Sekretariat ist täglich für Sie
erreichbar:
Montag – Freitag: 7.30 – 20.00 Uhr
Samstag und Sonntag: 9.00 – 18.00 Uhr
Internationaler Referenzstandort für
Cyberknife® & ZAP-X®
Europäisches Radiochirurgie
Centrum München
Max-Lebsche-Platz 31
D – 81377 München
Fax. (089) 45 23 36 – 16
Europäisches Radiochirurgie Centrum
München
Max-Lebsche-Platz 31
D – 81377 München
Fax. (089) 45 23 36 – 16
E-Mail: info@erc-munich.com
© Europäisches Radiochirurgie Centrum
München. Alle Rechte vorbehalten.